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Abstract
We used a bivariate (multivariate) linear mixed-effects model to estimate the narrow-sense heritability (h
2) and heritability
explained by the common SNPs (hg
2) for several metabolic syndrome (MetS) traits and the genetic correlation between pairs
of traits for the Atherosclerosis Risk in Communities (ARIC) genome-wide association study (GWAS) population. MetS traits
included body-mass index (BMI), waist-to-hip ratio (WHR), systolic blood pressure (SBP), fasting glucose (GLU), fasting insulin
(INS), fasting trigylcerides (TG), and fasting high-density lipoprotein (HDL). We found the percentage of h
2 accounted for by
common SNPs to be 58% of h
2 for height, 41% for BMI, 46% for WHR, 30% for GLU, 39% for INS, 34% for TG, 25% for HDL,
and 80% for SBP. We confirmed prior reports for height and BMI using the ARIC population and independently in the
Framingham Heart Study (FHS) population. We demonstrated that the multivariate model supported large genetic
correlations between BMI and WHR and between TG and HDL. We also showed that the genetic correlations between the
MetS traits are directly proportional to the phenotypic correlations.
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Introduction
Obesity associated traits such as central adiposity, dyslipidemia,
hypertension, and insulin resistance are major risk factors for type
2 diabetes and cardiovascular complications [1]. The constellation
of these traits has been termed metabolic syndrome (MetS).
Understanding the genetic factors underlying these traits and how
they are correlated is clinically important. Large-scale genotyping
investigations such as genome-wide association studies (GWAS)
are useful tools for identifying genetic factors. However, significant
genetic variants discovered in GWAS explain only a small
proportion of the expected narrow-sense heritability, h
2, defined
as the ratio of additive genetic variance to phenotypic variance [2].
This discrepancy underlies the debate concerning ‘‘missing’’
genetic factors among the common variants [3,4].
The main approach of GWAS has been to identify significant
single-nucleotide polymorphisms (SNPs) by examining each SNP
individually for significance. The h
2 attributed to that marker is
then given by 2f(12f)a
2,w h e r ef is the frequency of the marker
and a is the additive effect. To reduce the chance of false
positives, a stringent p-value criterion has been adopted (typically
p=5*10
28, based on an adjusted p-value of 0.05 for one-million
tests). It has been suggested that this selection criterion is too
conservative [5] and that some of the missing heritability may be
linked to genetic markers of small effect that fail this stringent
cutoff.
Alternatively, the narrow sense heritability explained by the
common SNPs, hg
2, may be estimated by adapting a linear mixed-
effects model [6,7] that is used to estimate h
2. This model
decomposes the phenotypic variance into genetic and residual
variance components. Usually, the model is applied to related
individuals where the genetic relationships are estimated by using
family pedigree or genetic markers [8,9]. Yang et al. [6,7] pointed
out that hg
2 could be estimated using genetic relationships obtained
from the common SNPs for unrelated individuals. The main
assumed difference between hg
2 and h
2 is due to the difference in
linkage disequilibrium (LD) between the common SNP markers
and the rest of the genome, with the assumption that closely
related individuals would be in greater LD than unrelated
individuals. Thus, heritability estimated with the genetic relation-
ships of unrelated individuals is attributed to the common variants
while that estimated with genetic relationships of related
individuals is attributed to the entire genome. While the method
does not identify single variants, it provides the maximum
expected variance expected by the set of markers or the relative
complement of the set (e.g., common versus rare variants).
Recently, it has been shown that a large proportion of h
2 is
explained by the common single-nucleotide polymorphisms (SNPs)
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proportions of the phenotypic variance for several metabolic
syndrome (MetS) traits were also captured by the common SNPs.
Among these, we validated the height and body-mass index
estimates by Yang et al. [6,7] in independent GWAS populations.
We also quantified the genetic correlation between traits explained
by the common SNPs.
Results
We estimated h
2 and hg
2 for height and body-mass index (BMI)
in the Framingham Heart Study population (FHS), and height and
seven metabolic syndrome traits (MetS) traits: BMI, waist-to-hip
ratio (WHR), systolic blood pressure (SBP), fasting glucose (GLU),
fasting insulin (INS), fasting triglycerides (TG), and fasting high-
density lipoprotein (HDL) in the Atherosclerosis Risk in Commu-
nities population (ARIC) (ARIC MetS estimates shown in Table 1).
Our base FHS population consisted of 4,240 subjects and our base
ARIC population consisted of 8,451 subjects (see Methods and
Tables S1 and S2 for a description of the populations). The genetic
relationship between pairs of subjects was estimated using 436,126
genome-wide common SNP markers for ARIC and 320,118 SNPs
for FHS (see Methods for details).
We first estimated h
2 for related individuals with relationships
between 0.35 and 0.65, derived empirically from the SNP
markers, for height and BMI in the ARIC and FHS populations
(see Methods for derivation of the relationship matrix). This
resulted in 3,663 subjects (6,706,953 pairs of subjects) for FHS and
530 subjects (140,185 pairs of subjects) for ARIC. We found h
2 to
be 0.77 (s.e. 0.03) for height and 0.39 (s.e. 0.04) for BMI in FHS,
and 0.88 (s.e. 0.09) for height and 0.34 (s.e. 0.12) for BMI in
ARIC. The estimated h
2 were consistent with values obtained
using phenotypic regression (data not shown) and previous results
[6,7,10,11].
We then compared these values to estimates for hg
2 for unrelated
individuals with relationships less than 0.025 (see Methods for
derivation of the relationship matrix). This resulted in 1,489
subjects (1,107,816 pairs of subjects) for FHS and 5,647 subjects
(31,882,962 pairs of subjects) for ARIC. As mentioned above, hg
2
provides an estimate of the heritability explained by common
variants because of presumed lesser linkage disequilibrium
between the common SNPs and the rest of the genome as
compared to related individuals. We found hg
2 to be 0.50 (s.e. 0.18)
for height and 0.10 (s.e. 0.18) for BMI in FHS, and 0.46 (s.e. 0.05)
for height and 0.14 (s.e. 0.05) for BMI in ARIC. These values are
consistent with previously estimated values [6,7]. Using the
average across FHS and ARIC estimates, this implied that the
common SNPs accounted for approximately 58% of h
2 for height
and 33% for BMI. To assess whether including more common
SNPs would explain more of the h
2, we examined how hg
2
depended on the number of SNPs. As shown in Figure S1, the
mean and standard error of the hg
2 estimate for height in the ARIC
population appeared to stabilize after approximately 300,000
SNPs.
We then estimated h
2 and hg
2 for the MetS traits in the ARIC
population using the same subjects as above (see Table 1). We
validated our h
2 estimates by using phenotypic regression between
related individuals for some of the traits (data not shown). The
median h
2 was 0.33, the minimum was 0.23 (INS), and the
maximum was 0.48 (HDL). The median hg
2 was 0.13, the
minimum was 0.09 (INS), and maximum was 0.24 (SBP).
Comparing the medians suggested that hg
2 explains ,39% of
the h
2 for these MetS traits. We found that the common SNPs
explained large proportions of the h
2: 41% of h
2 for BMI, 46% for
WHR, 30% for GLU, 39% for INS, 34% for TG, 25% for HDL,
and 80% for SBP.
We next estimated the genetic correlations between MetS traits
using a bivariate (multivariate) model (see Tables S3 and S4 for
covariances). Table 2 shows the genetic and residual correlations
for related individuals using bivariate models. The genetic
correlation is the additive genetic covariance between traits
normalized by the geometric mean of the individual trait genetic
variances. The residual correlation is similarly estimated using the
residual covariance and variances. For related individuals, we
found significant genetic correlations for BMI-WHR, WHR-INS,
GLU-INS, INS-TG, and TG-HDL and significant residual
correlations between BMI-WHR, BMI-INS, BMI-HDL, WHR-
INS, INS-HDL, and TG-HDL. Table 3 shows the genetic and
residual correlations for the unrelated individuals. We found
significant genetic correlations for BMI-WHR and TG-HDL and
significant residual correlations for all of the estimates except SBP-
Table 1. h
2 and hg
2 estimates (ARIC population).
BMI WHR GLU INS TG HDL SBP
h
2 0.34 (0.12) 0.28 (0.12) 0.33 (0.12) 0.23 (0.12) 0.47 (0.11) 0.48 (0.11) 0.30 (0.12)
hg
2 0.14 (0.05) 0.13 (0.05) 0.10 (0.05) 0.09 (0.05) 0.16 (0.05) 0.12 (0.05) 0.24 (0.05)
Mean and standard error estimates from univariate models.
doi:10.1371/journal.pgen.1002637.t001
Author Summary
The narrow-sense heritability of a trait such as body-mass
index is a measure of the variability of the trait between
people that is accounted for by their additive genetic
differences. Knowledge of these genetic differences
provides insight into biological mechanisms and hence
treatments for diseases. Genome-wide association studies
(GWAS) survey a large set of genetic markers common to
the population. They have identified several single markers
that are associated with traits and diseases. However,
these markers do not seem to account for all of the known
narrow-sense heritability. Here we used a recently
developed model to quantify the genetic information
contained in GWAS for single traits and shared between
traits. We specifically investigated metabolic syndrome
traits that are associated with type 2 diabetes and heart
disease, and we found that for the majority of these traits
much of the previously unaccounted for heritability is
contained within common markers surveyed in GWAS. We
also computed the genetic correlation between traits,
which is a measure of the genetic components shared by
traits. We found that the genetic correlation between
these traits could be predicted from their phenotypic
correlation.
Heritability of Metabolic Syndrome Traits
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proportional to the genetic correlations for related individuals (see
Figure S2) with a proportionality constant of 0.44 (s.e.=0.15 ; two-
tail t-distribution p-value with 20 d.f.=8.2*10
23). The phenotypic
correlations between traits were similar for related and unrelated
individuals and are shown in Table 4. These values were also
consistent with the reported estimates in the National Heart Lung
and Blood Institute-Family Heart Study (NHLBI-FHS), which
included Framingham Heart Study and ARIC families [11].
We validated our genetic correlation estimates using bivariate
models for each pair of traits by analyzing all 7 MetS traits
simultaneously for the unrelated individuals in a single multivar-
iate model. This 7 trait multivariate model was much more
expensive computationally so we used a less stringent convergence
rule. The results were similar to the bivariate model (see Table S5
and S6) although the genetic correlation increased and their error
decreased for a number of the estimates. In addition to the
significant genetic correlations in the bivariate models, we also
found the genetic correlation for BMI-INS to be significant in the
7 trait model.
We then examined the relationship between the genetic and
phenotypic correlations (see Figure S3). For related individuals, we
found that the phenotypic correlations rp were proportional to the
genetic correlations rg with a proportionality constant of 1.2
(s.e.=0.16; two-tail t-distribution p-value with 20 d.f.=3.1*10
27).
For unrelated individuals, we found that the phenotypic
correlations were proportional to the genetic correlations with a
proportionality constant of 0.85 (s.e.=0.19 ; two-tail t-distribution
p-value with 20 d.f.=2.3*10
24). The direct proportionality
between rp and rg implies that the ratio rg/rp is approximately
constant for the MetS traits.
Discussion
We used a recently developed approach to analyzing GWAS
data and provided new estimates for the total amount of additive
genetic information contained in the common SNPs for MetS
traits. The approach uses a linear mixed-effects model to estimate
the additive genetic variances and correlations between traits. The
model relies on knowing the genetic relationships between the
individuals analyzed. Previously, this had been obtained from
family pedigrees. Visscher et al. [9] and Yang et al. [6] observed
that the genetic relationships could be computed from the GWAS
SNPs. They also presumed that the heritability estimated for
unrelated individuals with low SNP correlation are explained
mainly by these common SNPs because the linkage disequilibrium
between the common SNPs and the rest of the genome is weak.
This would be in contrast to related individuals with high SNP
correlation where linkage disequilibrium is strong. Thus, herita-
bility estimated with the genetic relationships of unrelated
individuals is attributed to the common SNPs while that estimated
with the related individuals is attributed to the entire genome. This
then creates a major distinction between h
2 and hg
2. We computed
both in the same population. However, differences between
Table 2. Genetic and residual correlation coefficients between MetS traits in the ARIC population among related individuals from
the bivariate REML model.
BMI WHR GLU INS TG HDL SBP
BMI 0.75 (0.16)* 0.23 (0.24) 0.17 (0.27) 0.19 (0.20) 20.12 (0.21) 0.55 (0.24)
WHR 0.52 (0.08)* 0.35 (0.26) 0.67 (0.26)* 0.10 (0.22) 20.12 (0.22) 0.37 (0.26)
GLU 0.19 (0.12) 0.14 (0.12) 0.69 (0.25)* 0.21 (0.21) 20.07 (0.21) 0.13 (0.27)
INS 0.64 (0.08)* 0.35 (0.09)* 0.22 (0.11) 0.76 (0.21)* 20.33 (0.23) 0.29 (0.29)
TG 0.29 (0.12) 0.34 (0.12) 0.21 (0.13) 0.27 (0.11) 20.59 (0.13)* 0.21 (0.22)
HDL 20.38 (0.12)* 20.34 (0.12) 20.22 (0.13) 20.39 (0.11)* 20.45 (0.11)* 20.06 (0.23)
SBP 0.11 (0.12) 0.18 (0.11) 0.05 (0.12) 0.24 (0.11) 0.10 (0.13) 20.02 (0.13)
Mean and standard error of the Pearson correlation coefficient for genetic correlations (upper triangle) and residual correlations (lower triangle). An asterisk indicates
significance with p,0.05 adjusted for 21 hypotheses using the two-tailed hypothesis test and normal distribution of the Fisher transformed correlation coefficient.
doi:10.1371/journal.pgen.1002637.t002
Table 3. Genetic and residual correlations between MetS traits in the ARIC population among unrelated individuals from the
bivariate REML model.
BMI WHR GLU INS TG HDL SBP
BMI 0.91 (0.18)* 0.01 (0.32) 0.57 (0.24) 0.20 (0.24) 20.15 (0.28) 0.16 (0.20)
WHR 0.44 (0.03)* 0.09 (0.32) 0.33 (0.31) 0.32 (0.23) 20.06 (0.30) 0.17 (0.21)
GLU 0.27 (0.04)* 0.18 (0.04)* 0.05 (0.40) 0.07 (0.30) 20.16 (0.34) 0.11 (0.24)
INS 0.51 (0.03)* 0.40 (0.04)* 0.39 (0.04)* 0.22 (0.29) 20.20 (0.36) 0.20 (0.25)
TG 0.31 (0.04)* 0.33 (0.04)* 0.20 (0.04)* 0.43 (0.04)* 20.57 (0.19)* 0.002 (0.19)
HDL 20.34 (0.04)* 20.33 (0.04)* 20.16 (0.04)* 20.39 (0.04)* 20.51 (0.03)* 20.03 (0.22)
SBP 0.25 (0.05)* 0.18 (0.05)* 0.17 (0.05)* 0.22 (0.04)* 0.21 (0.05)* 20.04 (0.05)
Mean and standard error of the Pearson correlation coefficient for genetic correlations (upper triangle) and residual correlations (lower triangle). An asterisk indicates
significance with p,0.05 adjusted for 21 hypotheses using the two-tailed hypothesis test and normal distribution of the Fisher transformed correlation coefficient.
doi:10.1371/journal.pgen.1002637.t003
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2 and hg
2 may also arise due to differences in
environmental influences and non-additive genetic effects that
may bias the estimates. Provided that these biases are small then
the ratio of hg
2 to h
2 provides an estimate of the proportion of
narrow sense heritability captured by the common SNPs.
We confirmed previous findings that a large proportion of h
2 is
explained by the common SNPs. Our hg
2 estimates for height and
BMI in two independent analyses (i.e. ARIC and FHS) were
consistent with previously reported values [6,7]. Our h
2 estimates
for BMI, GLU, INS, TG, HDL, and SBP were similar to the
findings of the large family National Heart, Lung, and Blood
Institute (NHLBI) Family Heart Study [11], which included
Framingham Heart Study and ARIC families. We found that hg
2
explained a large proportion of h
2 across the MetS traits, and hg
2
explained approximately 39% of the h
2 for these traits. We
estimated that the common SNPs explain 58% of h
2 for height,
41% for BMI, 46% for WHR, 30% for GLU, 39% for INS, 34%
for TG, 25% for HDL, and 80% for SBP. Our hg
2 findings are
striking compared to traditional GWAS approaches where
significant common SNPs have been shown to explain only 4%
of h
2 for BMI with 32 SNPs, 11% for GLU with 14 SNPs, 20% for
TG with 48 SNPs, 25% for HDL with 60 SNPs, 3% for SBP with
10 SNPs, and 12% for height with 180 SNPs [12–16]. Height had
the largest absolute hg
2, which was consistent with having a large
h
2. Surprisingly, SBP had the largest proportion of h
2 explained by
the common SNPs while only a few percent of this has been
uncovered by traditional GWAS. However, the standard error of
hg
2 for SBP was large and reducing this error will be important for
further investigation. Conversely, our analysis suggested that the
SNP markers already identified for TG and HDL may contain the
maximum heritability expected from the common SNPs.
Our analysis of hg
2 against the number of SNPs suggested that
the mean and standard error of hg
2 for height is well estimated by
approximately 300,000 markers and that including more markers
would have little effect for this trait and perhaps others. The
standard error of hg
2 also increased with SNP number. This may
seem paradoxical but can be explained by recalling that the
estimate for hg
2 is proportional to the regression coefficient of the
square of the phenotype differences versus the genetic relationship
(i.e. Haseman-Elston regression) [8]. The standard error of hg
2 is
thus inversely proportional to the variance of the genetic
relationship. Since the latter is estimated from the common SNPs,
this variance is expected to decrease as the number of SNPs
increases thereby increasing the standard error [6].
Using the bivariate (multivariate) model [17,18] we estimated
the genetic and residual correlations between the MetS traits.
Among these, we found that the genetic correlations in related and
unrelated individuals for BMI and WHR were significantly
different from zero. This is consistent with both traits as indirect
measures of body fat and common health risks [19]. Previously,
Rice et al., 1994 [20] found significant genetic correlations
between BMI and SBP among normotensive nonobese families.
This suggested a common genetic etiology to their physiological
relationship through hyperinsulinemia resulting in increased renal
reabsorption of sodium and sympathetic activation [20]. We found
a large genetic correlation among related subjects, although it was
not significant because of the large error. This was consistent with
the large family study by the NHLBI that did not find a significant
genetic correlation [8]. Perusse et al, 1997 [21] argued that cross-
trait resemblance between BMI and lipids is mostly environmen-
tal. In concordance, we did not find significant genetic correlations
between either BMI or WHR and TG and HDL for either related
or unrelated individuals (see Table 3 and Table 4) while residual
(which includes environmental) correlations were significant for
BMI–HDL. We found that the residual covariance accounted for
a minimum of 71% (derived from the estimates in Table 4 and
Table S3) of the phenotype covariance between BMI or WHR and
the lipid measurements for related individuals. Genetic correla-
tions between TG and HDL were also large, which is consistent
with their direct physiological relationship [22]. This is also
consistent with the findings from a recent GWAS meta-analysis
whose results showed that 50% of the significant markers for TG
were also significant for HDL (derived from Supplementary
Tables 6 and 11 in [16]), and with a genome-wide LOD
correlation analysis [23]. While we found some significant genetic
correlations among both related and unrelated subjects, the
variance was large for these estimates and greater statistical power
is needed for better accuracy.
We found that the genetic correlation was directly proportional
to the phenotypic correlation, which was an unexpected, empirical
finding. Previously, a linear relationship between the correlations
was hypothesized by Cheverud for sets of traits with common
functions, and shown empirically for a number of traits [8,24–26].
While this finding is interesting from an evolutionary genetics
perspective, it may also serve a useful purpose in the maximum
likelihood computation of the linear mixed-effects model by
providing initial genetic correlation (i.e. covariance) estimates
based on the phenotypic correlations.
In summary, we provided evidence that the common SNPs
explain large proportions of the variance for several MetS traits in
agreement with previous findings for some of these traits [6,7].
This is consistent with the original premise of GWAS that a large
Table 4. Phenotypic correlation coefficients between MetS traits in the ARIC population.
BMI WHR GLU INS TG HDL SBP
BMI 0.59 (0.04)* 0.20 (0.04)* 0.49 (0.04)* 0.24 (0.04)* 20.26 (0.04)* 0.25 (0.04)*
WHR 0.51 (0.01)* 0.21 (0.04)* 0.43 (0.04)* 0.23 (0.04)* 20.24 (0.04)* 0.23 (0.04)*
GLU 0.24 (0.01)* 0.17 (0.01)* 0.34 (0.04)* 0.21 (0.04)* 20.15 (0.04)* 0.07 (0.04)
INS 0.52 (0.01)* 0.39 (0.01)* 0.35 (0.01)* 0.42 (0.04)* 20.35 (0.04)* 0.25 (0.04)*
TG 0.30 (0.01)* 0.33 (0.01)* 0.19 (0.01)* 0.40 (0.01)* 20.52 (0.04)* 0.14 (0.04)*
HDL 20.32 (0.01)* 20.30 (0.01)* 20.15 (0.01)* 20.37 (0.01)* 20.52 (0.01)* 20.04 (0.04)
SBP 0.23 (0.01)* 0.18 (0.01)* 0.15 (0.01)* 0.21 (0.01)* 0.16 (0.01)* 20.04 (0.01)*
Mean and standard error of the Pearson correlation coefficient. Coefficients among related individuals shown in the upper triangle. Coefficients among unrelated
individuals shown in the lower triangle. An asterisk indicates significance with p,0.05 adjusted for 21 hypotheses using the two-tailed hypothesis test and normal
distribution of the Fisher transformed correlation coefficient.
doi:10.1371/journal.pgen.1002637.t004
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to common variants [27]. However, an amendment to this premise
is that it is likely to be many common variants with small effect.
This is supported by recent meta-analyses with larger sample sizes
that have identified more associated common SNPs. This
approach can serve as a first approximation of the total heritability
expected from common SNPs given a genome-wide set of markers
and requires fewer subjects to achieve significant results. We also
found genetic associations that will be useful for single gene and
systems biology studies. Future studies with greater power will
provide estimates for weaker multivariate genetic associations and
provide greater precision for the estimates presented here.
Methods
ARIC population and GWAS data
Our main study population was the Atherosclerosis Risk In
Communities (ARIC) population. The ARIC population consists
of a large sample of unrelated individuals and some families across
North America. The population was recruited from four centers
across the United States: Forsyth County, North Carolina;
Jackson, Mississippi; Minneapolis, Minnesota; and Washington
County, Maryland. For this study, we restricted our analysis to the
European-American group. The population was recruited in 1987
from the general population consisting of subjects aged 45 to 64
years. The ARIC population consisted of 8,451 subjects.
Quality control and genotype calls for common SNPs were
evaluated previously for ARIC using the Affymetrix Human SNP
Array 6.0. We selected bilallelic autosomal markers based on the
following criteria: missingness ,0.05, Hardy-Weinberg equilibri-
um (p,10
26) and minor allele frequency .0.05. Subjects with
missingness .0.05 were removed. This resulted in 436,126
retained markers.
Quality control measurements from dbGAP (GENEVA ARIC
Project Quality Control Report Sept 22, 2009) indicate significant
population stratification between self-identified white (European-
ancestory kind group) and black populations when projected onto
HapMap components. Furthermore, principal-components anal-
ysis of the European-ancestory group by dbGAP showed that no
component explained more than 0.1% of the population variance.
For this study we only analyzed the European-ancestory group
and treated it as a single population.
ARIC phenotypes were adjusted for age, sex, and study center.
Only single measurements from visit 1 were used for these
subjects. We only used subjects with negative diabetes status and
with genotype and phenotype information for all traits. This
resulted in 8,451 subjects. We standardized all the traits. We first
log-transformed BMI, glucose, insulin, triglycerides, HDL, and
systolic blood pressure. All laboratory measurements are under
fasting conditions. Population trait statistics are in Table S1.
Framingham Heart Study (FHS) population
We estimated h
2 and hg
2 f o rh e i g h ta n dB M Ii nt h e
Framingham Heart Study population (FHS). The FHS
population is a large multi-generational dataset that started in
1948 in Framingham, Massachusetts in the United States. It
consists of a number of ethnicities predominantly from the
United Kingdom, Ireland, Italy, and Western Europe [28].
Markers were screened similarly to ARIC and we also removed
a n yS N P st h a td i dn o to v e r l a pw i th the ARIC set, which results
in 320,118 SNPs. We used principal components analysis of the
linkage disequilibrium (LD) pruned genetic relationship matrix
to identify components with variance .0.1%. LD pruning was
as in the ARIC 2009 report. This resulted in 73,432 retained
SNPs. We found three significant components that were then
used as covariates in the REML model. For consistency with
ARIC, we restricted the age range at time of exam to 45 to 65
years and randomly selected a single measurement in the case
of multiple measurements. Phenotypes were adjusted for age,
sex, and generation prior to the REML estimation and
standardized. We first log-transformed BMI. Population trait
statistics are in Table S2. Our base FHS population consisted of
4,240 subjects.
h
2 estimates using common SNP estimated relationship
We determined h
2 using the linear mixed-effects model (see
derivation below) and related individuals defined as genomic
relatedness between 0.35 and 0.65. We assume that the common
SNPs are in greater linkage disequilbrium among related
individuals and, as such, can be used to estimate the total
additive-genetic variance across the allele spectrum as suggested by
Visscher et al., 2006 [9]. We constrained the relationship matrix to
have at least one related pair per subject. This was done by
pruning the entire population relationship matrix by randomly
selecting a row and removing the row and its corresponding
column if no genomic covariance in the row was between the
cutoff values. For all pairs, including unrelated individuals, we
used their empirically defined relationship. This resulted in 530
individuals being selected for analysis in ARIC and 3,663
individuals in FHS.
h
2 was estimated with h
2=varg/(varg+vare), where varg and vare are
the genetic and residual variance components estimated by the
REML model using related individuals. The error was estimated
from the inverse Fisher Information (see linear mixed-effects
model below) and propagated using a first-order Taylor
expansion.
Common SNP linear mixed-effects model estimate of hg
2
We used the linear mixed-effects model and only unrelated
individuals to estimate the additive-genetic variance attributable to
the common SNPs (hg
2). Unrelated individuals were defined as
subjects with maximum genomic correlation of ,0.025. The
genomic relationship matrix was then produced as above based on
this cutoff. The cutoff was taken from Yang et al. 2010 [6] and is
less than the expected coefficient of relatedness between 2
nd
cousins. For these estimates we used the same group of 5,647
unrelated individuals for all estimates in ARIC and 1,489
individuals in FHS. hg
2 was estimated as hg
2=varg/(varg+vare),
where varg and vare are the genetic and residual variance
components estimated by the REML model using unrelated
individuals. The standard error was estimated as above. The
height hg
2 versus SNP number analyses were performed over allele
frequency range of 0.05 to 0.5 in order of increasing and
decreasing frequency.
Correlations
The genetic correlation (rg) is defined as rg~
covg(t1,t2)
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varg(t1)varg(t2)
p ,
where (varg(ti)) is the additive genetic variance of trait i and
covariance (covg(ti,tj)) is the additive genetic covariance between
the traits. The variances and covariances are estimated directly in
the multivariate linear mixed-effects model. The error was
computed from the estimated errors of the variances and
covariance using a first-order Taylor expansion. The residual
and phenotypic correlations were analogously defined. Phenotype
correlations and error were estimated by linear regression of the
standardized phenotypes.
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The mean and errors for proportionality constants between the
genetic and phenotypic correlations were determined by randomly
sampling over the distributions of the parameter estimates (i.e.
Monte Carlo method) assuming that the error around the mean
parameter estimate was normally distributed and that the
parameters were independent. We then fit a linear function with
the y-intercept fixed at 0 (after first confirming that it was not
significantly different from zero).
Significance testing
We assessed significance for correlation coefficients (r) using the
standardized Fisher transformed estimate of r: arctan(r)/arctan
(s.e.(r)). We estimated the two-tailed p-value from a normal
distribution and significance was determined by p,0.05 and
Bonferroni corrected for 21 hypotheses.
Significance for regression coefficient (b) was estimated using
the standardized coefficient b=s:e:(b). We estimated the two-tailed
p-value from a t-distribution and 20 degrees of freedom and
significance was determined by p,0.05.
Preprocessing of SNPs and phenotypes was done using PLINK
[29] (v1.07,http://pngu.mgh.harvard.edu/purcell/plink/) and
MATLAB (2010b, MathWorks, Natick, MA). REML optimization
was executed using software written in MATLAB.
Bivariate (multivariate) linear mixed-effects linear model
We considered the following multivariate linear mixed-effects
model for m individuals, n loci and t traits [6–8,17,18,30]:
yi~XivizZuizei
where yi is a m61 vector of trait i for m individuals, Xi is an m6s
fixed effects matrix for trait i, vi is a s61 vector of fixed effects
parameters for trait i, Z is an m6n matrix of standardized
genotypes, ui is an n61 vector of random effects for trait i
satisfying ui,N(0,G) and ei is an m61 vector of residual effects
satisfying ei,N(0,R), with matrix blocks Gij=covgijIn and
Rij=coveijIm and Il is the l6l identity matrix. This model can
be used for single or multiple traits. For two traits, it is called a
bivariate model. The model is identical to that used by [6,7,17].
We considered only bi-allelic SNPs in Hardy-Weinberg equilib-
rium.Denotetheminorallelebyqand the majorallele byQ.Let the
minor allele frequency at locus i have frequency pi. We assign a value
of2forgenotypeqq,1forgenotypeqQand0forgenotypeQQ.The
Hardy-Weinberg mean frequency for the genotype at locus i is 2pi
and the variance is 2pi(12pi). The standardized genotype entries
have values of (222pi)/(2pi(122pi))
1/2 for qq, (122pi)/(2pi(122pi))
1/2
for qQ, and 22pi/(2pi(122pi))
1/2 for the QQ genotype.
The log of the likelihood function is given by
L~{
n
2
ln 2p ðÞ {
1
2
ln V jj {
X t
i~1,j~1
yi{Xivi ðÞ V{1
ij yj{Xj
  
where the covariance matrix can be expressed as a tensor product
V~G6AzR6I with m6m blocks V
21
ij and A is the genetic
relationship matrix. Following Yang et al. [6], we used a modified
covariance matrix for A, A~ZZ’=n, where the diagonals of A are
computed using the formula
Akl~
1
n
X m
k~1
Zkl Zklz
2pl{1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2pl(1{pl)
p
 !
:
We use the restricted maximum likelihood (REML) approach [8]
where the gradients of the log likelihood are given by
LL
Lcovgij
~
1
2
y0PAijPy{
1
2
Tr(PAij)
LL
Lcoveij
~
1
2
y0PIijPy{
1
2
Tr(PIij)
where Iij is a tm6tm dimensional matrix with zero entries except
for a m6m identity matrix at block location i, j, Aij~A6Iij and
P~V{1{V{1Y(Y0V{1Y)
{1Y0V{1, where Y~It6Xi.
We solved the REML equations using an EM algorithm [8],
which was given by
(covgij)
kz1~(covgij)
kz
(covgij)
k
m
y0PkAijPky{Tr(PkAij)
  
(coveij)
kz1~(coveij)
kz
(coveij)
k
m
y0PkIijPky{Tr(PkIij)
  
for iteration k+1 in terms of iteration k. We iterated until the rate of
change of the log likelihood function was less than about 10
24.W e
also checked that the rate of change of the square of the covariance
predictions was less than 10
28. We checked our results against the
software developed by Yang et al. (GCTA) [31] for the univariate
model.
For the multivariate model, we transformed to a coordinate
system where the covariance matrices were diagonal [8] to speed up
the computation. Let zj be the set of phenotypes for individual j.W e
used the canonical transformation ~ z zj~Qzj such that QGQ
0~L
and QRQ
0~It. Q can be computed from the formula
Q~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SRS
0 p
S
{1 where SGR{1~LS,( S is the matrix of left
eigenvectors of GR
21). The transformed genetic covariances are
given by L and the residual covariances are It. Each step consisted
of taking a single step with the univariate EM algorithm for the
transformed additive genetic and residual variance followed by a
transformation back to the original coordinates. We iterated until
the maximum of the magnitudes of the components of the gradient
of the log likelihood function was less than approximately 5|10{4.
In our computations, we used both the direct EM algorithm and
the canonically transformed algorithm because even though the
transformed algorithm was in principle faster, it sometimes had poor
convergence properties if the initial guess was not sufficiently close to
the maximum likelihood value. We ensured that both give the same
results.Forcomputationalefficiency,theresultsshownarecomputed
from the bivariate model for the different trait pairs. We confirmed
our results with a multivariate model that included all traits.
Our error estimates were given by the inverse of the Fisher
information matrix F, which we computed by evaluating the
Hessian of the log likelihood at the maximum likelihood
predictions. F is a t(t+1)6t(t+1) dimensional matrix with rows
corresponding to the genetic and residual variances and
covariances (where covij was set equal to covji) and with block
elements (that are not all contiguous) given by
Fij,kl~
1
2
Tr(PAijPAkl) Tr(PAijPAkl)
Tr(PAijPIkl) Tr(PIijPIkl)
  
for iƒjand kƒl.
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Figure S1 Height hg
2 versus number of SNPs by sampling the
allele frequency from 0.05 to 0.5 (red=low to high, blue=high to
low, black=using all SNPs). A) hg
2 estimates for height relative to
the number of SNPs (mean and s.e.). B) Standard error versus
number of SNPs.
(TIF)
Figure S2 Genetic correlation coefficient for unrelated individ-
uals versus the genetic correlation coefficients for related
individuals. Shown are the mean and standard errors. Dashed
line is the least squares fit with the y-intercept fixed at 0 estimated
using a Monte Carlo method (slope=0.44).
(TIF)
Figure S3 A) Genetic correlation coefficients versus the
phenotypic correlation coefficients for related individuals. Shown
are the mean and standard errors. Dashed line is the least squares
fit with the y-intercept fixed at 0 estimated using a Monte Carlo
method (slope=1.2). B) Genetic correlation coefficients versus the
phenotype correlation coefficients for unrelated individuals.
Shown are the mean and standard errors. Dashed line is the least
squares fit with the y-intercept fixed at 0 estimated using a Monte
Carlo method (slope=0.85).
(TIF)
Table S1 Atherosclerosis Risk in Communities Study (ARIC)
population statistics by sex; mean (sd; minimum-maximum).
BMI=body-mass index, WC=waist circumference, WHR=wa-
ist-to-hip ratio, GLU=fasting glucose, INS=fasting insulin,
TG=fasting triglycerides, HDL=fasting high-density lipoprotein,
SBP=systolic blood pressure.
(DOCX)
Table S2 Framingham Heart Study (FHS) population statistics.
(DOCX)
Table S3 Genetic and residual covariance estimates for the
ARIC population among related individuals. Mean and standard
error of genetic (upper triangle) and residual (lower triangle)
covariance estimates from the univariate (diagonals) and bivariate
(off-diagonals) REML model.
(DOCX)
Table S4 Genetic and residual covariance estimates for the
ARIC population among unrelated individuals. Mean and
standard error of genetic (upper triangle) and residual (lower
triangle) covariance estimates from the univariate (diagonals) and
bivariate (off-diagonals) REML model.
(DOCX)
Table S5 Genetic (upper triangle) and residual (lower triangle)
correlations among unrelated individuals in the ARIC population
based on simultaneous analysis of all MetS traits. Mean and
standard error of the Pearson correlation coefficient for genetic
correlations (upper triangle) and residual correlations (lower
triangle). An asterisk indicates significance with p,0.05 adjusted
for 21 hypotheses using the two-tailed hypothesis test and normal
distribution of the Fisher transformed correlation coefficient.
(DOCX)
Table S6 Genetic (upper triangle) and residual (lower triangle)
covariances among unrelated individuals in the ARIC population
based on simultaneous analysis of all MetS traits. Mean and
standard error.
(DOCX)
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